Related Experiment Video
Updated: Aug 7, 2026
07:05
Mouse Model of Alloimmune-induced Vascular Rejection and Transplant Arteriosclerosis
Published on: May 17, 2015
[Immunomorphological study of coronary grafts]
Kardiologiia
|July 12, 2005
Summary
Angiotensin converting enzyme (ACE) contributes to coronary artery bypass graft occlusion by promoting smooth muscle cell proliferation and is found in macrophages within the graft intima. This suggests ACE is a key factor in bypass graft failure.
Area of Science:
- Cardiovascular Surgery
- Vascular Biology
- Enzymology
Context:
- Coronary artery bypass grafting (CABG) is a common surgical procedure to treat coronary artery disease.
- Graft occlusion is a frequent complication, leading to graft failure and adverse patient outcomes.
- Intimal hyperplasia is a primary pathological process driving graft occlusion.
Purpose:
- To investigate the role of angiotensin converting enzyme (ACE) in the development of coronary artery bypass graft occlusion.
- To identify the cellular localization of ACE within occluded bypass grafts.
Summary:
- High concentrations of ACE were detected in smooth muscle cells within the intimal hyperplasia zone of occluded grafts.
- ACE was also found in macrophages infiltrating the graft intima.
- These findings suggest ACE contributes to smooth muscle cell proliferation, hypertrophy, and extracellular matrix synthesis, all key factors in graft obstruction.
Impact:
- ACE inhibition could be a potential therapeutic strategy to prevent or reduce coronary artery bypass graft occlusion.
- Understanding ACE's role provides insights into the molecular mechanisms underlying graft failure.
- This research may lead to improved long-term patency rates for coronary bypass grafts.
